Valuation : Repligen Corporation

Market Cap 9.95B 8.57B 8.04B 7.34B 13.79B 947B 13.89B 95.3B 37.08B 480B 37.35B 36.54B 1,589B P/E 2026 *
233x
P/E 2027 * 102x
Enterprise Value 9.71B 8.36B 7.85B 7.17B 13.47B 924B 13.56B 93.06B 36.21B 469B 36.47B 35.68B 1,552B EV / Sales 2026 *
11.7x
EV / Sales 2027 * 9.84x
Free-Float
94.32%
Yield 2026 *
-
Yield 2027 * -
1 day+1.08%
1 week-1.97%
Current month+26.26%
1 month+26.26%
3 months+44.63%
6 months+44.68%
Current year+8.65%
1 week 174.01
Extreme 174.01
185.34
1 month 140.54
Extreme 140.54
188.73
Current year 100.99
Extreme 100.99
188.73
1 year 100.99
Extreme 100.99
188.73
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
8/20/26 Exercice

Chief Executive Officer

16,278 0.0288%
7/16/26 Sell

Chief Financial Officer

-530 0.0009%
6/25/26 Sell

Chief Financial Officer

-733 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-1.97%+47.52%+2.37% 9.95B
-2.01%-5.68%-16.29%+6.94% 195B
-0.41%-2.22%-2.67%+11.45% 117B
+0.36%-0.17%+9.62%+83.67% 61.45B
-0.85%-1.42%-0.07%-32.72% 51.62B
+0.80%-1.18%+27.79%+52.56% 51.03B
-0.47%-0.88%+21.48%-10.62% 34.27B
+0.41%+1.92% - - 30.95B
+1.26%-3.37%+40.07%-16.09% 23.75B
-0.91%-2.06%-5.54%+16.29% 23.41B
Average -0.09%-1.48%+13.55%+12.65% 59.78B
Weighted average by Cap. -0.70%-1.97%+0.98%+14.96%

Financials

2026 *2027 *
Net sales 827M 712M 669M 610M 1.15B 78.69B 1.15B 7.92B 3.08B 39.9B 3.11B 3.04B 132B 969M 835M 784M 715M 1.34B 92.22B 1.35B 9.29B 3.61B 46.76B 3.64B 3.56B 155B
Net income 41.92M 36.09M 33.89M 30.94M 58.12M 3.99B 58.54M 402M 156M 2.02B 157M 154M 6.7B 98.84M 85.1M 79.91M 72.94M 137M 9.4B 138M 947M 368M 4.77B 371M 363M 15.79B
Net Debt -234M -201M -189M -172M -324M -22.23B -326M -2.24B -871M -11.27B -877M -858M -37.33B -407M -351M -329M -301M -565M -38.76B -569M -3.9B -1.52B -19.65B -1.53B -1.5B -65.07B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-08-31 $177.95 +0.95% 209,965
26-08-28 $176.27 -3.16% 818,718
26-08-27 $182.03 +0.96% 611,896
26-08-26 $180.30 -0.77% 539,095
26-08-25 $181.69 +0.04% 1,142,346
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
176.27USD
Average target price
185.70USD
Spread / Average Target
+5.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock